Margareta Elisabeth Björk
Directeur/Membre du Conseil chez PHARVARIS N.V.
Fortune : 503 080 $ au 30/04/2024
Postes actifs de Margareta Elisabeth Björk
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/06/2012 | - |
| ROCKET PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 20/04/2020 | - |
| Independent Dir/Board Member | 20/04/2020 | - | |
| PHARVARIS N.V. | Directeur/Membre du Conseil | 01/12/2021 | - |
| Independent Dir/Board Member | 01/12/2021 | - | |
| CALLIDITAS THERAPEUTICS AB | Directeur/Membre du Conseil | 01/01/2022 | - |
| Independent Dir/Board Member | 01/01/2022 | - | |
| VICORE PHARMA HOLDING AB | Directeur/Membre du Conseil | 01/01/2023 | - |
| University of Uppsala | Corporate Officer/Principal | - | - |
| Chalmers University of Technology | Directeur/Membre du Conseil | - | - |
| Björks Matematik o Mera AB | Directeur/Membre du Conseil | - | - |
| Rfidcompare Europe AB | Directeur/Membre du Conseil | - | - |
Historique de carrière de Margareta Elisabeth Björk
Anciens postes connus de Margareta Elisabeth Björk
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formation de Margareta Elisabeth Björk
| University of Uppsala | Doctorate Degree |
| Karolinska Institutet | Doctorate Degree |
Statistiques
Internationale
| Suède | 9 |
| Royaume-Uni | 3 |
| Etats-Unis | 2 |
Opérationnelle
| Director/Board Member | 8 |
| Corporate Officer/Principal | 3 |
| Independent Dir/Board Member | 3 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 4 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| PHARVARIS N.V. | Health Technology |
| CALLIDITAS THERAPEUTICS AB | Health Technology |
| VICORE PHARMA HOLDING AB | Health Technology |
| Entreprise privées | 4 |
|---|---|
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Health Technology |
Uppsala University Hospital
 Uppsala University Hospital Hospital/Nursing ManagementHealth Services Uppsala University Hospital operates a hospital. | Health Services |
| Björks Matematik o Mera AB | |
| Rfidcompare Europe AB |
- Bourse
- Insiders
- Margareta Elisabeth Björk
- Expérience
